UPDATE : Wednesday, March 20, 2019
상단여백
US sales of J&J’s Remicade sink due to biosimilars’ challenge
The U.S. sales of Johnson & Johnson's (J&J) Remicade, a blockbuster ant...
by Lee Han-soo  |  2019-01-24 11:44
라인
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy
Kanzen said Tuesday that it has signed an agreement with Corea Therapeutics...
by Lee Han-soo  |  2019-01-23 21:29
라인
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
The Patent Court of Korea has rejected Jazz Pharmaceuticals’ application fo...
by Lee Hye-seon  |  2019-01-23 14:47
라인
Lilly returns rights for Hanmi’s BTK inhibitor candidate
Hanmi Pharmaceutical said Wednesday that Lilly has returned licensing right...
by Lee Han-soo  |  2019-01-23 10:21
라인
Bridge Biotherapeutics licenses in new targeted thearpy candidate
Bridge Biotherapeutics said Wednesday that it has signed a technology trans...
by Lee Han-soo  |  2019-01-23 10:20
라인
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has signed an agreement with Chong Kun D...
by Lee Han-soo  |  2019-01-22 16:03
라인
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’
The Korea Pharmaceutical Distribution Association (KPDA) is seeking to file...
by Park Gi-taek  |  2019-01-22 14:18
라인
BMS, Ono Pharma wins more indication for Opdivo in EU
Bristol-Myers Squibb (BMS) and Ono Pharma Korea have received an additional...
by Lee Han-soo  |  2019-01-21 18:01
라인
New HIV combo pill Biktarvy approved in Korea
Gilead Sciences said it has obtained approval for Biktarvy, a three-in-one ...
by Lee Hye-seon  |  2019-01-21 15:36
라인
JW wins sales go-ahead for hemophilia A treatment
JW Pharmaceutical said Sunday that the Ministry of Food and Drug Safety has...
by Lee Han-soo  |  2019-01-21 15:35
라인
Novo Nordisk increases market share for mixed insulin in Korea
Novo Nordisk Korea said Monday that Ryzodeg, the company’s soluble insulin ...
by Lee Han-soo  |  2019-01-21 14:44
라인
Sillajen releases interim results for combination cancer treatment in US
Sillajen said Monday that it has presented the National Cancer Institute’s ...
by Lee Han-soo  |  2019-01-21 14:20
라인
OliX unveils new drug candidate for treating geographic atrophy
Olix Pharmaceutical unveiled its latest drug candidate OLX10020, a treatmen...
by Lee Han-soo  |  2019-01-18 15:17
라인
‘Pharmaceuticals need President Moon’s committed support’
The chief of Korea’s representative biopharmaceutical industry group called...
by Lee Hye-seon  |  2019-01-17 17:39
라인
Daewoong to use cloud service for safe drug management
Daewoong Pharmaceutical said Thursday that it has introduced Oracle Argus C...
by Lee Han-soo  |  2019-01-17 15:37
라인
EN Cell to make Hanmi’s anti-cancer gene stem cell therapy
EN Cell said Thursday that it has signed a contract manufacturing organizat...
by Lee Han-soo  |  2019-01-17 12:34
라인
‘Tagrisso’s benefit as 1st-line treatment overrides resistance risk’
Will AstraZeneca’s targeted therapy Tagrisso (ingredient: osimertinib) soli...
by Park Gi-taek  |  2019-01-17 12:34
라인
Bridge Biotherapeutics’ idiopathic pulmonary fibrosis treatment wins orphan drug status
Bridge Biotherapeutics said Thursday that the U.S. Food and Drug Administra...
by Lee Han-soo  |  2019-01-17 11:04
라인
Daewoong, Yonsei University to develop customized diagnosis, treatment system for cancer patients
Daewoong Pharmaceutical said Wednesday that it has signed an industry-unive...
by Lee Han-soo  |  2019-01-16 17:19
라인
Genexine, NeoImmuneTech wins FDA nod for clinical trials of GX-I7
Genexine and NeoImmuneTech have received approval from the U.S. Food and Dr...
by Lee Han-soo  |  2019-01-16 16:12
여백
여백
여백
Back to Top